Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels (Q47249814)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels
scientific article

    Statements

    Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit